A Case of Refractory Vitiligo That Was Treated with a Combination of Non-ablative 1550-nm Erbium:Glass Fractional Laser, Narrow-band UVB, and a Topical Agent

Jae-Beom PARK; Ji-Hyun PARK; Seung-Hyun CHUN; Hee-Won JANG; Hwa-Jung RYU; Il-Hwan KIM.
Korean Journal of Dermatology ; : 280-283, 2016.
Artículo en Ko | WPRIM | ID: wpr-162885

Documentos relacionados

  1. Impacts of exposure to topical calcineurin inhibitors on metabolism in vitiligo infants.
  2. The efficacy of ablation-based combination therapy for vitiligo: A systematic review and meta-analysis.
  3. Topical Calcineurin Inhibitors in the Management of Chronic Pruritus in Older Adults: A Research Letter.
  4. Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients.
  5. The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy.
  6. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
  7. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses.
  8. A Comprehensive Review of Calcineurin Inhibitors Used for Immunosuppression in Cardiac Transplantation.
  9. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
  10. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients.